ANCA-associated vasculitis

AR Kitching, HJ Anders, N Basu, E Brouwer… - Nature reviews Disease …, 2020 - nature.com
The anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are a
group of disorders involving severe, systemic, small-vessel vasculitis and are characterized …

[HTML][HTML] Personalized redox medicine in inflammatory bowel diseases: an emerging role for HIF-1α and NRF2 as therapeutic targets

AR Bourgonje, D Kloska, A Grochot-Przęczek… - Redox Biology, 2023 - Elsevier
Inflammatory bowel diseases (IBD), encompassing Crohn's disease (CD) and ulcerative
colitis (UC), are intimately associated with inflammation and overproduction of reactive …

[HTML][HTML] A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE) …

NM Noor, JC Lee, S Bond, F Dowling… - The Lancet …, 2024 - thelancet.com
Background Management strategies and clinical outcomes vary substantially in patients
newly diagnosed with Crohn's disease. We evaluated the use of a putative prognostic …

New Insights on CD8+ T Cells in Inflammatory Bowel Disease and Therapeutic Approaches

R Casalegno Garduño, J Däbritz - Frontiers in immunology, 2021 - frontiersin.org
CD8+ T cells are involved in the pathogenesis of inflammatory bowel disease (IBD), a
complex multifactorial chronic disease. Here, we present an overview of the current research …

An immune dysfunction score for stratification of patients with acute infection based on whole-blood gene expression

E Cano-Gamez, KL Burnham, C Goh… - Science translational …, 2022 - science.org
Dysregulated host responses to infection can lead to organ dysfunction and sepsis, causing
millions of global deaths each year. To alleviate this burden, improved prognostication and …

Artificial intelligence for disease assessment in inflammatory bowel disease: how will it change our practice?

RW Stidham, K Takenaka - Gastroenterology, 2022 - Elsevier
Artificial intelligence (AI) has arrived and it will directly impact how we assess, monitor, and
manage inflammatory bowel disease (IBD). Advances in the machine learning …

Tumor necrosis factor inhibitors for inflammatory bowel disease

OH Nielsen, MA Ainsworth - New England Journal of Medicine, 2013 - Mass Medical Soc
Tumor Necrosis Factor Inhibitors for Inflammatory Bowel Disease | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …

Artificial intelligence applications in inflammatory bowel disease: emerging technologies and future directions

J Gubatan, S Levitte, A Patel… - World journal of …, 2021 - pmc.ncbi.nlm.nih.gov
Inflammatory bowel disease (IBD) is a complex and multifaceted disorder of the
gastrointestinal tract that is increasing in incidence worldwide and associated with …

Genetics and epigenetics of IBD

V Annese - Pharmacological research, 2020 - Elsevier
Inflammatory bowel diseases (IBD) are chronic intermittent inflammatory disorders of the
gastrointestinal tract of unknown etiology but a clear genetic predisposition. Prompted by the …

Longitudinal multi-omics analysis identifies early blood-based predictors of anti-TNF therapy response in inflammatory bowel disease

N Mishra, K Aden, JI Blase, N Baran, D Bordoni… - Genome medicine, 2022 - Springer
Background and aims Treatment with tumor necrosis factor α (TNFα) antagonists in IBD
patients suffers from primary non-response rates of up to 40%. Biomarkers for early …